The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications

참고문헌 (74)

1. Terasaki PI, "ed. History of HLA" (1990), UCLA Tissue Typing Laboratory Press
2. Bjorkman PJ, "Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987", pp.512~8
3. Beck S, "The human major histocompatibility complex: lessons from the DNA sequence", 1, pp.117~137 (2000)
4. Marsh SGE, "Nomenclature for factors of the HLA system, 2004", 65, pp.301~369 (2005)
5. Bjorkman PJ, "function and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990", pp.253~88
6. Saper MA, "Wiley DC. Structure of the human class I histocompatibility antigen", pp.506~12
7. Madden DR, "Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991", pp.321~5
8. Klein J, "The HLA system. First of two parts", 343, pp.702~709 (2000)
9. Brown JH, "et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993", pp.33~9
10. "Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 1994"
11. Falk K, "Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991", steva(vic s), pp.290~6
12. Zinkernagel RM, "Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974", pp.701~2
13. Garrett TP, "Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989", pp.692~6
14. Stern LJ, "Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 1994", pp.245~51
15. Pamer E, "Mechanisms of MHC class I- restricted antigen processing. Annu Rev Immunol 1998; 16:323-58.", 16, pp.323~358 (1998)
16. Cresswell P. Assembly, "and function of MHC class II molecules. Annu Rev Immunol 1994", pp.259~93
17. van der Merwe PA, "Molecular interactions mediating T cell antigen recognition", 21, pp.659~684 (2003)
18. Parham P, "Immunogenetics of killer-cell immunoglobulin-like receptors", 62, pp.194~200 (2003)
19. Terasaki PI, "McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964", pp.998~1000
20. Choo SY, "Hansen JA. Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules. Immunogenetics 1993", pp.108~13
21. The IMGT, "HLA Sequence Database", http:, www.ebi. ac.uk, pp.imgt, hla
22. Petersdorf EW, "A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing", 46, pp.73~85 (1995)
23. Johnson AH, "Butler WT. Detection of allo-antibodies using a sensitive antiglobulin micro- cytotoxicity test identification of low levels of pre- formed antibodies in accelerated allograft rejection. Tissue Antigens 1972", pp.215~26
24. McKenna RM, "Anti-HLA antibodies after solid organ transplantation", 69, pp.319~326 (2000)
25. Gebel HM, "Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk", 3, pp.1488~1500 (2003)
26. Flomenberg N, "Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome", 104, pp.1923~1930 (2004)
27. Petersdorf EW, "Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation", 42, pp.76~84 (2005)
28. Buckley RH, "27. Transplantation immunology: organ and bone marrow", 111(2 Suppl), pp.S733~S744 (2003)
29. Whitelegg A, "The structural basis of T-cell allorecognition", 63, pp.101~108 (2004)
30. Hauptman PJ, "Procurement and allocation of solid organs for transplantation", 336, pp.422~431 (1997)
31. "http:"[DOI]
32. "http:", policiesandbylaws, pp.policies.asp?resources=true
33. Jordan SC, "Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial", 15, pp.3256~3262 (2004)
34. Montgomery RA, "Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross- match-positive recipients", 70, pp.887~895 (2000)
35. Terasaki PI, "Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival", 28, pp.1144~1145 (1996)
36. Terasaki PI, "High survival rates of kidney transplants from spousal and living unrelated donors", 333, pp.333~336 (1995)
37. Thomas ED, "Bone marrow transplantation: a review", 36(4 Suppl 7), pp.95~103 (1999)
38. Schoemans H, "Adult umbilical cord blood transplantation: a comprehensive review", 38, pp.83~93 (2006)
39. "Martin PJ. The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 1990", pp.283~9
40. Cornelissen JJ, "Developments in T-cell depletion of allogeneic stem cell grafts", 7, pp.348~352 (2000)
41. Thomas ED, "et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 1974", pp.157~80
42. Beatty PG, "et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1984", pp.765~71
43. Beatty PG, "et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991", pp.443~7
44. McCullough J, "The National Marrow Donor Program with emphasis on the early years", 46, pp.1248~1255 (2006)
45. Karanes C, "Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program", 17, pp.1036~1167 (2003), Williston Park
46. Hurley CK, "Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers", 61, pp.415~424 (2003)
47. Petersdorf EW, "Effect of HLA mismatches on the outcome of hematopoietic transplants", 11, pp.521~526 (1999)
48. Morishima Y, "The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA- A, HLA-B, and HLA-DR matched unrelated donors", 99, pp.4200~4203 (2002)
49. Dickinson AM, "Non-HLA immunogenetics in hematopoietic stem cell transplantation", 17, pp.517~525 (2005)
50. Hurley CK, "National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants", 9, pp.610~615 (2003)
51. .Jones DC, "Natural killer receptor repertoires in transplantation", 30, pp.169~176 (2003)
52. Lowdell MW, "Natural killer cells in haematopoietic stem cell transplantation", 13, pp.399~404 (2003)
53. Goulmy E, "Human minor histocompatibility antigens", 8, pp.75~81 (1996)
54. Smeenk RJ, "Eernisse JG. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 1981", pp.84~9
55. Abou-Elella AA, "Low incidence of red cell and HLA antibody formation by bone marrow transplant patients", 35, pp.931~935 (1995)
56. Thomas ED, "et al. Marrow transplantation for aplastic anemia. Semin Hematol 1984", pp.27~35
57. van Marwijk-Kooy M, "Akkerman JW. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization", pp.201~5
58. Sintnicolaas K, "Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen- alloimmunization and refractoriness: a randomized prospective study", 85, pp.824~828 (1995)
59. McFarland JG, "Slichter SJ. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989", pp.380~6
60. Doughty HA, "Waters AH. Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 1994"
61. International Forum, "Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors", 84, pp.73~88 (2003)
62. Rachel JM, "Plapp FV. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 1988", pp.63~8
63. Seftel MD, "Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness", 103, pp.333~339 (2004)
64. Petz LD, "et al. Transfusion-associated graft- versus-host disease in immunocompetent patients report of a fatal case associated with transfusion of blood from a second-degree relative and a survey of predisposing factors. Transfusion 1993", pp.742~50
65. Shivdasani RA, "Anderson KC. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease. Leuk Lymphoma 1994", pp.227~34
66. Davey RJ, "Transfusion-associated graft-versus-host disease and the irradiation of blood components", 24, pp.431~434 (1995)
67. Popovsky MA, "Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985", pp.573~7
68. Kopko PM, "TRALI: correlation of antigen-antibody and monocyte activation in donor- recipient pairs", 43, pp.177~184 (2003)
69. Silliman CC, "The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study", 37, pp.719~726 (1997)
70. Valentin N, "et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990", big(n jd), pp.73~9
71. Saito S, "Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies", 43, pp.908~917 (2003)
72. Thorsby E, "Invited anniversary review: HLA associated diseases", 53, pp.1~11 (1997)
73. Feder JN, "A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis", 13, pp.399~408 (1996)
74. Pena SD, "Chakraborty R. Paternity testing in the DNA era. Trends Genet 1994", pp.204~9

관련 논문AI추천